With ondansetron, comparison of propofol and remimazolam besilate for the prevention of postoperative nausea and vomiting.

With ondansetron, comparison of propofol and remimazolam besilate for the prevention of postoperative nausea and vomiting. - With ondansetron, comparison of propofol and remimazolam besilate for the prevention of postoperative nausea and vomiting.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000046237

Enrollment

Registered

2021-11-30

Start date

2022-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients undergoing laparoscopic gynecologic surgery

Interventions

General anesthesia with propofol. Ondansetron was administered. General anesthesia with remimazolam besilate. Ondansetron was administered.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists(ASA) physical status of I-III.

Exclusion criteria

Exclusion criteria: American Society of Anesthesiologists(ASA) physical status of IV-V. Patients without consent. Pregnant woman.

Design outcomes

Primary

Measure	Time frame
frequency of the postoperative nausea and vomiting	—

Countries

Japan

Contacts

Public ContactNami Kakuta

Tokushima University Hospital Anesthesiology

kakuta.nami@tokushima-u.ac.jp088-633-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026